NasdaqGM - Nasdaq Real Time Price • USD
Inhibrx, Inc. (INBX)
As of 10:10 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -1.51 | -1.47 | -5.86 | -6.17 |
| Low Estimate | -1.57 | -1.48 | -5.88 | -6.17 |
| High Estimate | -1.46 | -1.47 | -5.85 | -6.17 |
| Year Ago EPS | -1.08 | -1.1 | -5.12 | -5.86 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | 1.99M |
| Low Estimate | -- | -- | -- | 1.99M |
| High Estimate | -- | -- | -- | 1.99M |
| Year Ago Sales | 30k | -- | 1.8M | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.03 | -1.01 | -1.04 | -1.04 |
| EPS Actual | -1.08 | -1.1 | -1.73 | -1.44 |
| Difference | -0.05 | -0.09 | -0.69 | -0.4 |
| Surprise % | -4.90% | -8.90% | -66.30% | -38.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.51 | -1.47 | -5.86 | -6.17 |
| 7 Days Ago | -1.05 | -1.02 | -3.94 | -4 |
| 30 Days Ago | -1.05 | -1.02 | -3.94 | -4 |
| 60 Days Ago | -1.05 | -1.02 | -3.94 | -4 |
| 90 Days Ago | -1.04 | -1.02 | -4.12 | -2.58 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 2 | 2 | 2 | 1 |
Growth Estimates
| CURRENCY IN USD | INBX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -39.80% | -- | -- | 8.00% |
| Next Qtr. | -33.60% | -- | -- | 12.40% |
| Current Year | -14.50% | -- | -- | 5.60% |
| Next Year | -5.30% | -- | -- | 12.60% |
| Next 5 Years (per annum) | -- | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | JMP Securities: Market Outperform to Market Perform | 1/23/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 11/20/2023 |
| Maintains | JMP Securities: Outperform to Outperform | 8/23/2023 |
| Reiterates | JMP Securities: Market Outperform | 5/10/2023 |
| Maintains | JMP Securities: Market Outperform | 3/8/2023 |
| Reiterates | Credit Suisse: Outperform | 3/7/2023 |
Related Tickers
KROS Keros Therapeutics, Inc.
51.64
-1.22%
LIANY LianBio
0.3211
-1.37%
TIL Instil Bio, Inc.
11.35
-1.32%
ZNTL Zentalis Pharmaceuticals, Inc.
11.95
-1.04%
EWTX Edgewise Therapeutics, Inc.
17.90
-1.16%
GLTO Galecto, Inc.
0.6250
+0.63%
ORIC ORIC Pharmaceuticals, Inc.
9.16
0.00%
IVA Inventiva S.A.
3.8300
+0.79%
ALVR AlloVir, Inc.
0.7603
-1.95%
SYBX Synlogic, Inc.
1.6800
+1.82%